- Home
- LIMN vs TERN Comparison
LIMN vs TERN Comparison
Compare LIMN & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIMN
- TERN
- Stock Information
- Founded
- LIMN 2018
- TERN 2017
- Country
- LIMN United States
- TERN United States
- Employees
- LIMN N/A
- TERN N/A
- Industry
- LIMN
- TERN Biotechnology: Pharmaceutical Preparations
- Sector
- LIMN
- TERN Health Care
- Exchange
- LIMN NYSE
- TERN Nasdaq
- Market Cap
- LIMN 623.8M
- TERN 531.9M
- IPO Year
- LIMN N/A
- TERN 2021
- Fundamental
- Price
- LIMN $5.93
- TERN $5.47
- Analyst Decision
- LIMN
- TERN Buy
- Analyst Count
- LIMN 0
- TERN 5
- Target Price
- LIMN N/A
- TERN $15.63
- AVG Volume (30 Days)
- LIMN 987.0K
- TERN 1.0M
- Earning Date
- LIMN 01-01-0001
- TERN 08-12-2025
- Dividend Yield
- LIMN N/A
- TERN N/A
- EPS Growth
- LIMN N/A
- TERN N/A
- EPS
- LIMN N/A
- TERN N/A
- Revenue
- LIMN N/A
- TERN N/A
- Revenue This Year
- LIMN N/A
- TERN N/A
- Revenue Next Year
- LIMN N/A
- TERN N/A
- P/E Ratio
- LIMN N/A
- TERN N/A
- Revenue Growth
- LIMN N/A
- TERN N/A
- 52 Week Low
- LIMN $4.40
- TERN $1.87
- 52 Week High
- LIMN $33.66
- TERN $11.40
- Technical
- Relative Strength Index (RSI)
- LIMN N/A
- TERN 56.99
- Support Level
- LIMN N/A
- TERN $5.57
- Resistance Level
- LIMN N/A
- TERN $6.10
- Average True Range (ATR)
- LIMN 0.00
- TERN 0.28
- MACD
- LIMN 0.00
- TERN -0.06
- Stochastic Oscillator
- LIMN 0.00
- TERN 41.04
About LIMN LIMINATUS PHARMA INC
Liminatus Pharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing cancer therapies and treatments. The GCC Vaccine of the company is in Phase II of clinical trials designed for immune behavior towards colorectal, pancreatic, gastric, and esophageal cancers that express Guanylyl Cyclase C.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.